Robert DelAversano

Robert DelAversano

Director of Finance/CFO at ACASTI PHARMA INC.

Net worth: - $ as of 31/03/2024

52 year
Health Technology
Health Services
Consumer Services

Profile

Robert J.
DelAversano
is currently the Chief Financial & Accounting Officer at Acasti Pharma, Inc. and the Vice President-Finance & Controller at OncoSec Medical, Inc. Previously, he worked as the Director-Financial Reporting & Taxation at Brio Consultants LLC and as the Chief Financial & Accounting Officer at U.S.
Gold Corp.
from 2017 to 2018.
He also served as a Manager at Bartolomei Pucciarelli LLC.
Mr. DelAversano completed his undergraduate degree at Rider University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/05/2024 0 ( -.--% ) - $ 31/03/2024
21/03/2023 1,008 ( 0.02% ) - $ 31/03/2024

Robert DelAversano active positions

CompaniesPositionStart
ONCOSEC MEDICAL INCORPORATED Comptroller/Controller/Auditor 30/01/2020
ACASTI PHARMA INC. Director of Finance/CFO 05/01/2024
All active positions of Robert DelAversano

Former positions of Robert DelAversano

CompaniesPositionEnd
U.S. GOLD CORP. Director of Finance/CFO 01/11/2018
Corporate Officer/Principal -
Bartolomei Pucciarelli LLC Corporate Officer/Principal -
See the detail of Robert DelAversano's experience

Training of Robert DelAversano

Rider University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert DelAversano's experience

Connections

13

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ACASTI PHARMA INC.

Health Technology

ONCOSEC MEDICAL INCORPORATED

Health Services

U.S. GOLD CORP.

Non-Energy Minerals

Private companies2

Finance

Bartolomei Pucciarelli LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Robert DelAversano
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW